Light And Dark Studio / Shutterstock.com
PDL BioPharma has sued Merck Sharp & Dohme (MSD) in a complaint that centres on a now-expired patent directed to treating melanoma.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at email@example.com
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Merck Sharp & Dohme, patent infringement, PDL BioPharma, Keytruda, melanoma, US District Court for the District of New Jersey